🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the pharmacokinetics (PK) of AL-33...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-09-11
Trial ID
NCT03277755
Treatments Being Tested
This is a double-blind study evaluating Desvenlafaxine Succinate Sustained-...
Status
Completed
Location
Children's Hospital of Alabama Laboratory
Start Date
2011-08
Trial ID
NCT01371734
Treatments Being Tested
This is a 6-month, open-label, flexible-dose study evaluating Desvenlafaxin...
Status
Completed
Location
The University Of Alabama At Birmingham, Office Of Psychiatric Research
Start Date
2012-02-02
Trial ID
NCT01371708
Treatments Being Tested
To determine the bioequivalence of 2 tablets of 25 mg sustained release (SR...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-09
Trial ID
NCT01190514
The purpose of this study is to evaluate the safety and tolerability of AL-...
Status
Completed
Location
CAP Research Ltd
Start Date
2015-10-31
Trial ID
NCT02569710
Treatments Being Tested
This is a Double-blind Study Evaluating Desvenlafaxine Succinate (DVS SR) S...
Status
Completed
Location
Harmonex Neuroscience Research, Inc.
Start Date
2011-11-17
Trial ID
NCT01372150
Treatments Being Tested
In this Phase 4 trial we will study the safety, tolerability and efficacy o...
Status
Completed
Location
Rush University Medical Center
Start Date
2010-12
Trial ID
NCT02058693
Treatments Being Tested
Desvenlafaxine succinate (DVS SR) is a serotonin and norepinephrine reuptak...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-12
Trial ID
NCT00401245
Treatments Being Tested
The primary purpose of this study is to compare the long-term efficacy and ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-06
Trial ID
NCT00887224
This is a 6-month, open-label, flexible-dose study evaluating desvenlafaxin...
Status
Completed
Location
Harmonex Neuroscience Research, Inc.
Start Date
2012-02
Trial ID
NCT01371721
Treatments Being Tested